Stockholders’ Equity (Tables)
|
3 Months Ended |
12 Months Ended |
May 31, 2024 |
Feb. 29, 2024 |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
|
Schedule of Share Based Payments Award Stock Options Valuation Assumptions
Assumptions:
| | |
2024 | |
| Dividend yield | |
| 0.00 | % |
| Risk-free interest rate | |
| 0.19-4.05 | % |
| Expected volatility | |
| 100.2
– 122.8 | % |
| Expected life (in years) | |
| 5 | |
|
| Schedule of Stock Option Activity |
Option
activity for the three months ended May 31, 2024 and the year ended February 29, 2024 was as follows:
Schedule of Stock Option Activity
| | |
Options | | |
Weighted
Average
Exercise
Price ($) | | |
Weighted
Average
Remaining
Contractual
Life (Yrs.) | | |
Aggregate
Intrinsic
Value ($) | |
| | |
| | |
| | |
| | |
| |
| Options outstanding at February 28, 2023 | |
| - | | |
| - | | |
| - | | |
| - | |
| Options assumed pursuant to reverse acquisition | |
| 86,642 | | |
| 61.43 | | |
| 2.68 | | |
| - | |
| Granted | |
| - | | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (1,342 | ) | |
| 120.87 | | |
| - | | |
| - | |
| Options outstanding at February 29, 2024 | |
| 85,300 | | |
| 60.50 | | |
| 2.52 | | |
| - | |
| Granted | |
| - | | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (5,740 | ) | |
| 67.69 | | |
| - | | |
| - | |
| Options outstanding May 31, 2024 | |
| 79,560 | | |
| 59.84 | | |
| 2.27 | | |
| - | |
| Options expected to vest in the future as of May 31, 2024 | |
| 2,572 | | |
| 33.82 | | |
| 3.3 | | |
| - | |
| Options exercisable at May 31, 2024 | |
| 76,988 | | |
| 60.71 | | |
| 2.23 | | |
| - | |
| Options vested, exercisable, and options expected to vest at May 31, 2024 | |
| 79,560 | | |
| 59.84 | | |
| 2.27 | | |
| - | |
|
Option
activity for the year ended February 29, 2024 was as follows:
Schedule of Stock Option Activity
| | |
| | |
Weighted Average | | |
Weighted Average | | |
| |
| | |
| | |
Exercise | | |
Remaining | | |
Aggregate | |
| | |
| | |
Price | | |
Contractual | | |
Intrinsic | |
| | |
Options | | |
($) | | |
Life (Yrs.) | | |
Value ($) | |
| Options outstanding at February 28, 2023 | |
| - | | |
| - | | |
| - | | |
| | |
| Options assumed pursuant to reverse acquisition | |
| 86,642 | | |
| 61.43 | | |
| 2.68 | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (1,342 | ) | |
| 120.87 | | |
| - | | |
| - | |
| Options outstanding at February 29, 2024 | |
| 85,300 | | |
| 60.50 | | |
| 2.52 | | |
| - | |
| Options expected to vest in the future as of February 29, 2024 | |
| 3,451 | | |
| 33.25 | | |
| 3.54 | | |
| - | |
| Options exercisable at February 29, 2024 | |
| 81,849 | | |
| 61.64 | | |
| 2.48 | | |
| - | |
| Options vested, exercisable, and options expected to vest at February 29, 2024 | |
| 85,300 | | |
| 60.50 | | |
| 2.52 | | |
| - | |
|
| Schedule of Warranty Activity |
Warrant
activity for the three months ended May 31, 2024 and the year ended February 29, 2024 was as follows:
Schedule of Warranty Activity
| | |
Warrants | | |
Weighted
Average
Exercise
Price ($) | | |
Weighted
Average
Remaining
Contractual
Life (Yrs.) | |
| Warrants outstanding at February 28, 2023 | |
| - | | |
| - | | |
| - | |
| Warrants assumed pursuant to reverse acquisition | |
| 217,593 | | |
| 21.01 | | |
| 1.86 | |
| Granted | |
| 268,572 | | |
| 3.02 | | |
| 2.17 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| - | | |
| - | | |
| - | |
| Warrants outstanding at February 29, 2024 | |
| 486,165 | | |
| 9.94 | | |
| 1.96 | |
| Granted | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (2,102 | ) | |
| 322.00 | | |
| - | |
| Warrants outstanding at May 31, 2024 | |
| 484,063 | | |
| 8.58 | | |
| 1.71 | |
|
Warrant
activity for the year ended February 29, 2024 was as follows:
Schedule of Warranty Activity
| | |
| | |
Weighted Average | | |
Weighted Average | |
| | |
| | |
Exercise | | |
Remaining | |
| | |
| | |
Price | | |
Contractual | |
| | |
Warrants | | |
($) | | |
Life (Yrs.) | |
| Warrants outstanding at February 28, 2023 | |
| - | | |
| - | | |
| - | |
| Warrants assumed pursuant to reverse acquisition | |
| 217,593 | | |
| 21.01 | | |
| 1.86 | |
| Granted | |
| 268,572 | | |
| 3.02 | | |
| 2.17 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| - | | |
| - | | |
| - | |
| Warrants outstanding at February 29, 2024 | |
| 486,165 | | |
| 9.94 | | |
| 1.96 | |
|
| Stock Appreciation Rights [Member] |
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
|
The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for
the twelve months ended February 29, 2024:
Assumptions:
Schedule of Share Based Payments Award Stock Options Valuation Assumptions
| | |
2024 | |
| Dividend yield | |
| 0.00 | % |
| Risk-free interest rate | |
| 0.22-2.79 | % |
| Expected volatility | |
| 108.7-122.8.0 | % |
| Expected life (in years) | |
| 5 | |
|
| Schedule of Stock Option Activity |
SARs
activity for the three months ended May 31, 2024 and the year ended February 29, 2024 was as follows:
Schedule of Stock Option Activity
| | |
Options | | |
Weighted
Average
Exercise
Price ($) | | |
Weighted
Average
Remaining
Contractual Life (Yrs.) | | |
Aggregate
Intrinsic
Value ($) | |
| | |
| | |
| | |
| | |
| |
| SARs outstanding at February 28, 2023 | |
| - | | |
| - | | |
| - | | |
| - | |
| SARs assumed pursuant to reverse acquisition | |
| 40,390 | | |
| 44.77 | | |
| 2.99 | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| - | | |
| - | | |
| - | | |
| - | |
| SARs outstanding at February 29, 2024 | |
| 40,390 | | |
| 44.77 | | |
| 2.99 | | |
| - | |
| Granted | |
| - | | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (167 | ) | |
| 37.40 | | |
| - | | |
| - | |
| SARs outstanding May 31, 2024 | |
| 40,223 | | |
| 44.80 | | |
| 2.73 | | |
| - | |
| SARs expected to vest in the future as of May 31, 2024 | |
| 6,670 | | |
| 34.77 | | |
| 2.98 | | |
| - | |
| SARs exercisable at May 31, 2024 | |
| 33,553 | | |
| 46.79 | | |
| 2.69 | | |
| - | |
| SARs vested, exercisable, and SARs expected to vest at May 31, 2024 | |
| 40,223 | | |
| 44.80 | | |
| 2.73 | | |
| - | |
|
SARs
activity for the year ended February 29, 2024 was as follows:
Schedule of Stock Option Activity
| | |
| | |
Weighted Average | | |
Weighted Average | | |
| |
| | |
| | |
Exercise | | |
Remaining | | |
Aggregate | |
| | |
| | |
Price | | |
Contractual | | |
Intrinsic | |
| | |
SARs | | |
($) | | |
Life (Yrs.) | | |
Value ($) | |
| SARs outstanding at February 28, 2023 | |
| - | | |
| - | | |
| - | | |
| - | |
| SARs assumed pursuant to reverse acquisition | |
| 40,390 | | |
| 44.77 | | |
| 2.99 | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| - | | |
| - | | |
| - | | |
| - | |
| SARs outstanding February 29, 2024 | |
| 40,390 | | |
| 44.77 | | |
| 2.99 | | |
| - | |
| SARs expected to vest in the future as of February 29, 2024 | |
| 6,886 | | |
| 35.25 | | |
| 3.23 | | |
| - | |
| SARs exercisable at February 29, 2024 | |
| 33,504 | | |
| 46.72 | | |
| 2.93 | | |
| - | |
| SARs vested, exercisable, and options expected to vest at February 29, 2024 | |
| 40,390 | | |
| 44.77 | | |
| 2.99 | | |
| - | |
|